Low cerebrospinal fluid Aβ42 and Aβ40 are related to white matter lesions in cognitively normal elderly

Manuscript Number: 

17-0950R1

Author(s): 
Kaj Blennow, Anne Börjesson-Hanson, Xinxin Guo, Silke Kern, Ingmar Skoog, Henrik Zetterberg, Svante Östling

Disclosures

Kaj Blennow

  • Consulting Fees:
    KB has served as a consultant or at advisory boards for Alzheon, BioArctic, Biogen, Eli Lilly, Fujirebio Europe, IBL International, Merck, Novartis, Pfizer, and Roche Diagnostics. These activities were not related to the present study.
    Patents/Royalties
    KB is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg. This company was not involved in any aspect of this study.

Anne Börjesson-Hanson

  • Nothing to Disclose

Xinxin Guo

  • Nothing to Disclose

Silke Kern

  • Nothing to Disclose

Svante Östling

  • Nothing to Disclose

Ingmar Skoog

  • Consulting Fees:
    Takeda Consulting fee twice last 2 years
    Lecture Fees:
    Takeda, 1-2 times per year

Henrik Zetterberg

  • Nothing to Disclose